News Alert

Federal Judge Upholds Louisiana’s 340B Contract Pharmacy Law in Another Major Blow to Drug Industry

A federal court upheld Louisiana’s contact pharmacy law this week, drawing praise from provider groups and criticism from the drug industry in the latest of such challenges across the nation.
A federal judge moments ago dismissed three drug industry challenges to Louisiana’s 340B contract pharmacy access law in another major [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

News Alert

House Passes Pediatric Enrollment Bill That Would Require 340B Providers to Report Medicaid Managed Care Revenue

The U.S. House passed a bipartisan bill Tuesday evening to streamline Medicaid enrollment for pediatric providers that would also increase reporting requirements for certain 340B providers.
The U.S. House passed a bipartisan bill Tuesday evening to streamline Medicaid enrollment for pediatric providers that would also increase [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

News Alert

340B Covered Entities Threaten Action Against Drugmakers Over New Reporting Requirements

Second Sight Solutions updated 340B ESP's terms of use on Oct. 4.
A law firm representing hospitals and other 340B covered entities across the U.S. has called on more than two dozen [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

News Alert

Welch Introduces 340B PATIENTS Act in the Senate

U.S. Sen. Peter Welch (D-VT) introduced a Senate version of the 340B PATIENTS Act.
A Vermont Democrat has introduced Senate legislation to codify providers’ ability to use contract pharmacies to dispense 340B discounted drugs, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

News Alert

EMD Serono Extends 340B Contract Pharmacy Restrictions to All Covered Entities & Adds New Restrictions

EMD Serono wordmark on building
Beginning Oct. 1, EMD Serono will extend its contract pharmacy restrictions to all 340B covered entities.
A Boston-based biopharmaceutical company will soon extend its contract pharmacy restrictions from hospitals to all 340B covered entities (CEs), except [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

News Alert

HRSA Says Johnson & Johnson’s New 340B Rebate Model Did Not Receive Agency Approval, Is ‘Inconsistent’ with 340B Statute

HRSA did not approve J&J's newly proposed 340B rebate model, an agency spokesperson told 340B Report.
The federal agency that oversees the 340B program did not approve drugmaker Johnson & Johnson’s (J&J’s) proposal to convert certain [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

News Alert

Two Hospitals Sue HRSA to Block ‘Unlawfully Authorized’ Drugmaker 340B Program Audits

Oregon Health & Science University Hospital is one of two 340B hospitals to sue HRSA over approving a drugmaker audit. (Photo by M.O. Stevens)
Two 340B hospitals urged a federal district court to block drugmaker Johnson & Johnson (J&J) from conducting “unlawfully authorized” audits [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

News Alert

Massachusetts 340B Measures Addressing PBM Discrimination and Medicaid Drug Coverage Fall Short in Senate, Sponsor Plans to Refile Bill Next Session

A contract pharmacy access bill could still pass in Massachusetts despite the end of the formal legislative session.
The Massachusetts Senate on Thursday failed to adopt legislation that would have prohibited pharmacy benefit managers (PBMs) from imposing discriminatory [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

News Alert

340B Coalition Conference Keynote: Program Faces ‘Progress Amid Challenges’

Maureen Testoni, president and CEO of 340B Health, gave a keynote "state of 340B" address July 8 at the 340B Coalition summer conference.
The 340B program faces unprecedented challenges despite a series of states enacting 340B contract pharmacy access laws, the leader of [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

News Alert

AbbVie, AstraZeneca Challenge Kansas’ New Contract Pharmacy Access Law

AbbVie will no longer offer voluntary 340B pricing on any of its orphan-designated drugs to covered entities subject to such exclusions.
Two major drug manufacturers this week sued Kansas in an effort to block the state’s new contract pharmacy access law, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live